Biocytogen

Preclinical Services

>The Mouse Model and Efficacy Evaluation of Immunological Checkpoint

Gene description

TNFRSF9 (TNF receptor super family member 9), also called CD137 or 4-1BB, is mainly expressed on the surface of activated T, NK, and mononuclear cells. CD137 is activated by its ligand CD137L or an activating CD137 monoclonal antibody, and stimulates T cell activation, proliferation and cytokine production. This co-stimulatory signal can also multiply antigen presenting cells and result in cell factor secretion. Experiments show that CD137 co-stimulation regulates T cell and antigen presenting cell function for antitumor immunity, providing new targets for tumor immunological therapies.


Human 4-1BB Ab (Urelumab) mAb efficacy evaluation (MC38 cell line) 

blob.png

Fig1. Murine colon cancer MC38 cells were subcutaneously implanted into homozygous B-h4-1BB mice. Mice were divided into control and treatment groups (n=6), when the tumor size was approximately 150±50 mm3. Three doses Urelumab showed substantially inhibitory effects in the homozygous B-h4-1BB mice, suggesting that B-h4-1BB mouse model is a useful tool for in vivo h4-1BB antibody efficacy study. The average ± SEM of tumor sizes are shown in the figure.


Humna 4-1BB (Urelumab Analog) mAb toxicity evaluation

blob.png


Fig2.The blood routine examination was performed with anti-human 4-1BB antibody on B-h4-1BB mice at the termination of efficacy evaluation experiment.


blob.png


Humna 4-1BB (Urelumab Analog) mAb toxicity evaluation


blob.png

Fig3.The blood biochenmical index was examined with anti-human 4-1BB antibody on B-h4-1BB mice at the termination of efficacy evaluation experiment.

blob.png


Human 4-1BB (Utomilumab Analog) mAb Efficacy Evaluation (MC38 cell line)

blob.png


Fig4. Murine colon cancer MC38 cells were subcutaneously implanted into homozygous B-h4-1BB mice. Mice were divided into control and treatment groups (n=6), when the tumor size was approximately 150±50 mm3. The result indicated that substantially inhibitory effects in the homozygous B-h4-1BB mice, suggesting that B-h4-1BB mouse model is a useful tool for in vivo h4-1BB antibody efficacy study. The average ± SEM of tumor sizes are shown in the figure.


Human 4-1BB (Utomilumab Analog) mAb toxicity Evaluation

blob.png

Fig5.The blood biochenmical index was examined with anti-human 4-1BB antibody on B-h4-1BB mice at the termination of efficacy evaluation experiment.

blob.png

【Return list】
* Contact Name
* Quantity
Telephone No.
Email
* Shipping address
Verification code captcha
© 2018 Beijing Biocytogen Co., Ltd. All rights reserved. Technical support: fast help cloud